Top News
OAB Symptoms Increase With Longer BCG Therapy for NMIBC
PRE Training Improved Self-Efficacy, Promoted Symptom Management in Patients With Lung Cancer
Genomic Markers May Predict Clinical Outcomes in Patients With B-Cell Acute Lymphoblastic Leukemia
FDA Authorizes Moderna, Janssen COVID-19 Booster Shots, Allows for Mix and Match
Inbox Time Linked to Reduced Odds of Physician Turnover
Tafasitamab Plus Lenalidomide and Rituximab for Follicular Lymphoma and Marginal Zone Lymphoma
Trial Comparing Pirtobrutinib With Bendamustine Plus Rituximab in CLL/SLL
Online Calculator May Predict Treatment-Related Hearing Loss in Children With Cancer
U.S. Spending Up for Cancer Drugs Lacking Evidence of Survival Benefit
Prostate Cancer Observation Varies With MRI, Genomic Testing Availability
FDA Approves Lenalidomide Capsules in 2.5mg, 20mg Strengths
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Equal Access to Care May Eliminate Racial Disparities in Lung Cancer Outcomes
One study suggested that modifiable factors could improve racial disparities in the stage at which lung cancer is diagnosed. -
Second Dose of COVID-19 Vaccine Not Enough for Some Patients With Cancer
About half of patients with impaired seroconversion after the first dose of a COVID-19 vaccine still had low antibody levels after the second dose. -
Pandemic-Related Delays in Cancer Surgery May Not Affect Short-Term Outcomes
There was no increase in unresectable disease, new metastatic disease, or 30-day mortality associated with increasing delays. -
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse
More than one-third of tumors sequenced carried a high mutation burden. -
Breast, Prostate Cancer Common in Patients With COVID-19 and Cancer History
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases. -
Adult Participation in Cancer Trials Higher Than Previously Thought
Enrollment rates varied widely by study type and institution. -
Microaggressions and Lack of Tailored Resources: Challenges for LGBTQ+ Patients With Cancer
Survey responses revealed a lack of culturally competent care and tailored resources. -
Eligibility Criteria for Pancreatic Cancer Trials Exclude More Black Patients Than White Patients
Standard eligibility criteria perpetuate racial disparities and are often not medically justifiable, according to researchers. -
Data Hide ‘Critical Disparities’ in Nasopharyngeal Carcinoma Incidence Among Asian Americans
The incidence was highest among Laotian and Chinese Americans.
More Features
First-Line Immunotherapy Continues to Best Chemo in Malignant Pleural Mesothelioma
Data suggest nivolumab plus ipilimumab provides a long-term survival benefit in patients with unresectable malignant pleural mesothelioma.
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Medical Billing Outsourcing Is on the Rise
Contracting with outside firms to handle medical billing can be a smart financial move for some medical practices.
Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
Improving Black Representation in Oncology: ‘Be the Change’
Only 3% of medical oncologists in the United States are Black.
- Loading...
Loading...
Loading... 
Loading...